Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2025-08-28
2025-12-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Validation of iCare IC1000 Tonometer
NCT06748092
iCare IC1000 Alignment Study
NCT07022054
Icare Versus Haag-Streit Applanation Tonometer
NCT01159340
Clinical Study of the Topcon Tonometer TRK-3
NCT05167773
iCare HOME2 Clinical Trial
NCT05162989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iCare ST500 and iCare IC200 vs GAT and Tonovera
iCare ST500
Measurement of IOP
iCare IC200
Measurement of IOP
GAT
Measurement of IOP
Tonovera
Measurement of IOP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iCare ST500
Measurement of IOP
iCare IC200
Measurement of IOP
GAT
Measurement of IOP
Tonovera
Measurement of IOP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Subjects having poor or eccentric fixation in the study eye
3. High corneal astigmatism \>3D in the study eye
4. Central corneal scarring
5. History of prior incisional glaucoma surgery or corneal surgery, including corneal refractive laser surgery in the study eye
6. Microphthalmos
7. Buphthalmos
8. Contact lens use within one week of continuous wear and within one hour if lens is worn occasionally
9. Dry eyes (clinically significant)
10. Lid squeezers - blepharospasm
11. Nystagmus
12. Keratoconus
13. Any other corneal or conjunctival pathology or infection relevant to this study
14. Central corneal thickness greater than 600 μm or less than 500 μm in the study eye
15. Cataract Extraction within last 2 months in the study eye
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icare Finland Oy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NVision Clinical Research LLC
Torrance, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TA04-310
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.